David J. Figueroa

8.5k total citations · 2 hit papers
44 papers, 3.8k citations indexed

About

David J. Figueroa is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, David J. Figueroa has authored 44 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Physiology and 8 papers in Oncology. Recurrent topics in David J. Figueroa's work include Asthma and respiratory diseases (6 papers), Renal cell carcinoma treatment (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). David J. Figueroa is often cited by papers focused on Asthma and respiratory diseases (6 papers), Renal cell carcinoma treatment (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). David J. Figueroa collaborates with scholars based in United States, United Kingdom and Chile. David J. Figueroa's co-authors include Christopher P. Austin, Konstantin Petrukhin, Jilly F. Evans, Michael L. Metzker, Wen Li, C. Thomas Caskey, Elisabeth A. Minthorn, Debra J. Gilbert, Robert J. Gould and Neal G. Copeland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

David J. Figueroa

43 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the gene responsible for Best macular dystrophy

1998 541 citations Konstantin Petrukhin, Benjamin Bakall et al. Nature Genetics profile →
Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity

2013 364 citations Charity Atkins, Qi Liu et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Figueroa United States	23	2.0k	758	568	557	551	44	3.8k
Koji Igarashi Japan	33	3.5k 1.8×	520 0.7×	559 1.0×	337 0.6×	427 0.8×	116	4.8k
Nina S. Levy Israel	30	2.7k 1.4×	306 0.4×	332 0.6×	485 0.9×	668 1.2×	60	5.1k
Derek P. Brazil United Kingdom	35	4.7k 2.4×	446 0.6×	957 1.7×	555 1.0×	724 1.3×	81	7.3k
Przemysław Sapieha Canada	43	3.0k 1.5×	630 0.8×	244 0.4×	678 1.2×	493 0.9×	96	5.8k
Shan Zhu China	24	2.6k 1.3×	840 1.1×	520 0.9×	537 1.0×	378 0.7×	86	5.3k
Shinichi Harada Japan	30	1.5k 0.8×	304 0.4×	773 1.4×	331 0.6×	391 0.7×	129	3.3k
Anne Vital France	34	1.7k 0.8×	950 1.3×	224 0.4×	199 0.4×	1.2k 2.2×	129	4.7k
Florian Sennlaub France	45	2.5k 1.3×	427 0.6×	268 0.5×	1.0k 1.9×	451 0.8×	127	6.1k
Antonio Feliciello Italy	37	2.4k 1.2×	508 0.7×	234 0.4×	219 0.4×	351 0.6×	67	3.5k

Countries citing papers authored by David J. Figueroa

Since Specialization

Citations

This map shows the geographic impact of David J. Figueroa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Figueroa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Figueroa more than expected).

Fields of papers citing papers by David J. Figueroa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Figueroa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Figueroa. The network helps show where David J. Figueroa may publish in the future.

Co-authorship network of co-authors of David J. Figueroa

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Figueroa. A scholar is included among the top collaborators of David J. Figueroa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Figueroa. David J. Figueroa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Usmani, Saad Z., Hang Quach, Youngil Koh, et al.. (2021). DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma. Blood. 138(Supplement 1). 2738–2738. 15 indexed citations

Washburn, Michael L., Zhang Wang, Andrew H. Walton, et al.. (2019). T Cell– and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer. The Journal of Immunology. 203(7). 1897–1908. 38 indexed citations

Choueiri, Toni K., David J. Figueroa, André P. Fay, et al.. (2014). Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial. Clinical Cancer Research. 21(5). 1071–1077. 187 indexed citations

Choueiri, Toni K., David J. Figueroa, Yuan Liu, et al.. (2014). Correlation of PDL1 tumor expression and treatment outcomes in patients with renal cell carcinoma (RCC) receiving tyrosine kinase inhibitors: COMPARZ study analysis.. Journal of Clinical Oncology. 32(4_suppl). 416–416. 8 indexed citations

Atkins, Charity, Qi Liu, Elisabeth A. Minthorn, et al.. (2013). Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity. Cancer Research. 73(6). 1993–2002. 364 indexed citations breakdown →

Alsaid, Hasan, Weike Bao, David J. Figueroa, et al.. (2011). Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction. Magnetic Resonance in Medicine. 67(1). 191–200. 5 indexed citations

Yu, Yan, Hong Jin, Daniel Holder, et al.. (2010). Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury. Nature Biotechnology. 28(5). 470–477. 147 indexed citations

Figueroa, David J., et al.. (2008). Phospholipidosis Assay in HepG2 Cells and Rat or Rhesus Hepatocytes Using Phospholipid Probe NBD-PE. Assay and Drug Development Technologies. 6(3). 407–419. 31 indexed citations

Gerhold, David, Ansuman Bagchi, Meiqing Lu, et al.. (2007). Androgens drive divergent responses to salt stress in male versus female rat kidneys. Genomics. 89(6). 731–744. 15 indexed citations

10.

Xia, Menghang, Yuan Liu, David J. Figueroa, et al.. (2004). Characterization and localization of a human serine racemase. Molecular Brain Research. 125(1-2). 96–104. 60 indexed citations

11.

Kinney, Gene G., Cyrille Sur, Maryann Burno, et al.. (2003). The Glycine Transporter Type 1 InhibitorN-[3-(4′-Fluorophenyl)-3-(4′-Phenylphenoxy)Propyl]Sarcosine Potentiates NMDA Receptor-Mediated ResponsesIn Vivoand Produces an Antipsychotic Profile in Rodent Behavior. Journal of Neuroscience. 23(20). 7586–7591. 147 indexed citations

12.

Parent, Stephen A., Theresa Zhang, Gary Chrebet, et al.. (2002). Molecular characterization of the murine SIGNR1 gene encoding a C-type lectin homologous to human DC-SIGN and DC-SIGNR. Gene. 293(1-2). 33–46. 19 indexed citations

13.

Figueroa, David J., Jill A. Morris, Lei Ma, et al.. (2002). Presenilin-Dependent Gamma-Secretase Activity Modulates Neurite Outgrowth. Neurobiology of Disease. 9(1). 49–60. 35 indexed citations

14.

Figueroa, David J., Richard Breyer, Stacia Kargman, et al.. (2001). Expression of the Cysteinyl Leukotriene 1 Receptor in Normal Human Lung and Peripheral Blood Leukocytes. American Journal of Respiratory and Critical Care Medicine. 163(1). 226–233. 225 indexed citations

15.

Liu, Qingyun, Xiao Ming Guan, William J. Martin, et al.. (2001). Identification and Characterization of Novel Mammalian Neuropeptide FF-like Peptides That Attenuate Morphine-induced Antinociception. Journal of Biological Chemistry. 276(40). 36961–36969. 233 indexed citations

16.

Hui, Yiqun, Helen Galczenski, David J. Figueroa, et al.. (2001). The Murine Cysteinyl Leukotriene 2 (CysLT2) Receptor. Journal of Biological Chemistry. 276(50). 47489–47495. 70 indexed citations

17.

Petrukhin, Konstantin, Benjamin Bakall, Wen Li, et al.. (1998). Identification of the gene responsible for Best macular dystrophy. Nature Genetics. 19(3). 241–247. 541 indexed citations breakdown →

18.

Fahy, John V., et al.. (1997). Similar RANTES Levels in Healthy and Asthmatic Airways by Immunoassay and In Situ Hybridization. American Journal of Respiratory and Critical Care Medicine. 155(3). 1095–1100. 21 indexed citations

19.

González, Manuel C., et al.. (1989). Intrahepatic cholestasis of pregnancy in twin pregnancies. Journal of Hepatology. 9(1). 84–90. 146 indexed citations

20.

Dulac, Olivier, David J. Figueroa, Enrique Rey, & M Arthuis. (1983). [Monotherapy with clobazam in epilepsies in children].. PubMed. 12(17). 1067–9. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact